GX 12
Alternative Names: GX-12; HIV DNA vaccine - Dong-A Pharmaceutical; Naked DNA vaccine for HIV-1 infections - Dong-ALatest Information Update: 27 Jul 2010
At a glance
- Originator Dong-A Pharmaceutical; Genexine
- Developer Dong-A Pharmaceutical
- Class AIDS vaccines; DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 01 Aug 2007 Phase-I clinical trials in HIV-1 infections in South Korea (IM)
- 01 Aug 2007 Phase-I clinical trials in HIV-1 infections in South Korea (IV)
- 30 Jun 2003 Preclinical trials in HIV infections in South Korea (IM)